Inflammation in the genesis and perpetuation of atrial fibrillation.

@article{Engelmann2005InflammationIT,
  title={Inflammation in the genesis and perpetuation of atrial fibrillation.},
  author={Mads D.M. Engelmann and Jesper Hastrup Svendsen},
  journal={European heart journal},
  year={2005},
  volume={26 20},
  pages={
          2083-92
        }
}
The prevalence and persistence of atrial fibrillation (AF) and the relative inefficacy of the currently available pharmacotherapy requires development of new treatment strategies. Recent findings have suggested a mechanistic link between inflammatory processes and the development of AF. Epidemiological studies have shown an association between C-reactive protein and both the presence of AF and the risk of developing future AF. In case-control studies, C-reactive protein is significantly… 
Update on the Association of Inflammation and Atrial Fibrillation
TLDR
The purpose of this review is to provide current evidence on the relationship between inflammation and AF and potential therapies available to modulate the inflammatory state in AF.
The Emerging Role of Inflammation and Fibrosis in Atrial Fibrillation and the Potential of Counter Interventions
TLDR
Data from five comparative studies of a primary rate control vs. rhythm control strategy for patients with a history of AF failed to show a significant superiority of rhythm control, highlighting the limited efficacy and high side-effect profile of the currently available anti-arrhythmic drugs.
Pleiotropic effects of statins in atrial fibrillation patients: the evidence
TLDR
Despite a growing body of evidence that drugs with anti-inflammatory properties such as statins may prevent AF, the observed positive effects of statins on the burden of AF appeared to be independent of their cholesterol-reducing properties.
Is atrial fibrillation an inflammatory disorder?
TLDR
An overview of the evidence supporting a link between inflammation and AF, and some of the drug therapies that might be efficacious in the prevention of AF by modulating inflammatory pathways are presented.
Is atrial fibrillation an inflammatory disease?
Inflammatory markers in paroxysmal atrial fibrillation and the protective role of renin-angiotensin-aldosterone system inhibitors
TLDR
Inflammation is present in patients with AF, with or without treatment with RAAS inhibitors and is correlated with longer duration of AF, left atrial diameter andleft atrial volume.
Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease.
  • Ying Luan, Yuanyuan Guo, +10 authors Ye Tian
  • Medicine, Biology
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2010
TLDR
Interleukin-18 may be superior to other inflammatory markers which are known to be elevated in atrial fibrillation patients, and this study documents the elevated IL-18 in AF patients.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 78 REFERENCES
Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress.
TLDR
The role of inflammation and oxidative stress in AF deserves further study, since amelioration of atrial electrical remodeling by conventional antiarrhythmics has been proved ineffective.
C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation
TLDR
Elevated CRP levels in AF patients may reflect an inflammatory state that promotes the persistence of AF, and is the first to document elevated CRP in non-postoperative arrhythmia patients.
C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation
TLDR
CRP has a strong association with PAF and support the hypothesis that CRP is a potent determinant of successful cardioversion of PAF in sinus rhythm.
C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?
TLDR
It is suggested that inflammation is a causative agent of paroxysmal AF and not a consequence of atrial fibrillation.
Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial.
TLDR
The results show that management of AF with the rhythm-control strategy offers no survival advantage over the rate- control strategy, and suggests that efforts to reduce the structural changes that occur during AF may be more useful in preventing recurrences than efforts designed to minimize the electrical changes alone.
Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs
TLDR
Simvastatin attenuates AF promotion by atrial tachycardia in dogs, an effect not shared by antioxidant vitamins, and constitutes a potentially interesting new pharmacological approach to preventing the consequences of atrial fibrillation remodeling.
Inflammation as a Risk Factor for Atrial Fibrillation
TLDR
CRP is not only associated with the presence of AF but may also predict patients at increased risk for future development of AF.
C-reactive Protein and Atrial Fibrillation
TLDR
It is suggested that inflammation is a causative agent of paroxysmal AF and not a cause or consequence of atrial fibrillation.
Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease.
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.
...
1
2
3
4
5
...